Randomized double-blind trial shows Hydergine improves attitude and behavior in geriatric cerebrovascular insufficiency, suggesting clinical benefit without adverse effects.
Seventy‐eight geriatric patients with symptoms and signs of cerebrovascular insufficiency were treated either with Hydergine or a placebo in a randomized, double‐blind manner for twelve weeks. Changes in the patients' condition were measured in three areas—attitude and behavior, cognitive and intellectual capacities, and clinical status (physical complaints). Analysis of the data revealed that Hydergine most significantly improved items pertaining to the patients' attitude and behavior. No untoward effects were observed.
No takes yet. Share an insight, caveat, or question.
DAVID M. BANEN (1972) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: